Covid-19 ‘antibody cocktail’ drug reported to be 81 percent protective

In a written statement from the company, it was noted that Regen-Cov’s 3rd phase trial results showed that patients with Covid-19 were 72 percent effective in the first week and 93 percent in the following weeks. In the statement, it was stated that if Regen-Cov is applied subcutaneously, it reduces the risk of getting Covid-19 in non-infected by 81 percent. Pointing out that Regen-Cov is an important development for high-risk groups that have not yet…

"Covid-19 ‘antibody cocktail’ drug reported to be 81 percent protective"